Veterinary drug residue detection method

By mixing multiple single samples of the same animal product categories and using liquid chromatography tandem mass spectrometer to detect, the problem of low efficiency of veterinary drug residue detection in the prior art is solved, and efficient and accurate veterinary drug residue detection is achieved.

CN118937527APending Publication Date: 2024-11-12SHENZHEN INSTITUTE OF QUALITY & SAFETY INSPECTION & RESEARCH (SHENZHEN CENTER FOR ANIMAL DISEASE CONTROL & PREVENTION)
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411145183.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-20
Publication Date
2024-11-12

AI Technical Summary

Technical Problem

The existing veterinary drug residue detection methods are inefficient and require multiple analysis of each animal and poultry sample and aquatic product, which consumes time and human resources.

Method used

Provide mixed samples, including a single sample of multiple types of animal products, the total content of original veterinary drugs is detected by liquid chromatography tandem mass spectrometer, and the total content of various veterinary drugs is obtained according to the target standard curve, thereby determining the veterinary drug content of a single sample , realize efficient mixed inspection.

Benefits of technology

It improves the efficiency and accuracy of veterinary drug residue detection, realizes simultaneous screening and efficient mixed inspection of multiple veterinary drugs, and reduces the number of tests and the consumption of human resources.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118937527A_ABST
    Figure CN118937527A_ABST
Patent Text Reader

Abstract

The invention discloses a veterinary drug residue detection method, relates to the technical field of veterinary drug detection, and discloses a veterinary drug residue detection method, which comprises: providing a mixed sample, the mixed sample comprising a plurality of single samples belonging to the same animal product category; detecting the original veterinary drug total content of various veterinary drugs in the mixed sample through a liquid chromatography tandem mass spectrometer; according to the target standard curve matched with the animal product category to which the mixed sample belongs, correcting the original veterinary drug content of each veterinary drug to obtain the target veterinary drug total content of each veterinary drug; and according to the target veterinary drug total content of each veterinary drug, determining the veterinary drug seed content of each veterinary drug of each single sample contained in the mixed sample. According to the invention, efficient detection of veterinary drug residues is realized.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present application relates to the technical field of veterinary drug detection, and in particular to a method for detecting veterinary drug residues. Background Art

[0002] With increasingly stringent food safety standards, the monitoring of veterinary drug residues in animal agricultural products (including animal and poultry products and aquatic products) has been significantly strengthened. However, in the current testing process, facing the huge and complex testing needs (covering 11 categories and a total of 64 types of veterinary drug residues, such as β-stimulants, glucocorticoids, etc.), there are many challenges. Since each veterinary drug testing step is cumbersome and the equipment is frequently used, each animal and poultry sample, aquatic product, etc. needs to undergo multiple analyses, which greatly consumes time and human resources.

[0003] The above contents are only used to assist in understanding the technical solution of the present application and do not constitute an admission that the above contents are prior art. Summary of the invention

[0004] The main purpose of this application is to provide a method for detecting veterinary drug residues, aiming to improve the detection efficiency of veterinary drug residues.

[0005] To achieve the above objectives, the present application provides a method for detecting veterinary drug residues, the method comprising:

[0006] providing a composite sample, wherein the composite sample comprises a plurality of individual samples belonging to the same animal product category;

[0007] Detecting the total original veterinary drug content of various veterinary drugs in the mixed sample by liquid chromatography tandem mass spectrometry;

[0008] Correcting the original veterinary drug content of each type of veterinary drug according to a target standard curve that matches the animal product category to which the mixed sample belongs, to obtain a target total veterinary drug content of each type of veterinary drug;

[0009] According to the target total veterinary drug content of each type of veterinary drug, the veterinary drug sub-content of each type of veterinary drug in each single sample contained in the mixed sample is determined.

[0010] In one embodiment, the animal product categories include livestock and poultry, aquatic products and eggs. Before the step of correcting the original veterinary drug content of each type of veterinary drug according to the target standard curve matching the animal product category to which the mixed sample belongs to obtain the target total veterinary drug content of each type of veterinary drug, the step further includes:

[0011] Pork was used as a blank matrix to establish a standard curve matching livestock and poultry;

[0012] Using fish meat as blank matrix, a standard curve matching aquatic products was established;

[0013] Eggs were used as blank matrix to establish an egg-matched standard curve.

[0014] In one embodiment, after the step of determining the veterinary drug content of each veterinary drug in each single sample contained in the mixed sample, the method further includes:

[0015] In the case where the veterinary drug sub-content of each veterinary drug in each single sample contained in the mixed sample is less than the preset veterinary drug limit value, it is determined that each single sample contained in the mixed sample is a negative sample; or,

[0016] In the event that the corresponding veterinary drug content in a single sample contained in the mixed sample is greater than or equal to the preset veterinary drug limit value, the single sample with the veterinary drug content greater than or equal to the veterinary drug limit value is determined as a suspected positive sample, and the suspected positive sample is retested as a single sample.

[0017] In one embodiment, the step of determining the veterinary drug sub-content of each type of veterinary drug in each single sample contained in the mixed sample according to the target veterinary drug total content of each type of veterinary drug comprises:

[0018] According to the total target veterinary drug content of each type of veterinary drug and the number of single samples contained in the mixed sample, the veterinary drug sub-content of each type of veterinary drug in each single sample contained in the mixed sample is determined, wherein the veterinary drug sub-content and the number of single samples are positively correlated.

[0019] In one embodiment, the step of providing a mixed sample comprises:

[0020] Obtaining the product to be inspected and crushing it to obtain a preparatory single sample, wherein the mass of the product to be inspected is greater than the mass of the preparatory single sample;

[0021] Taking a portion of the sample from the prepared single sample as the target single sample;

[0022] A plurality of the target single samples belonging to the same animal product category are mixed evenly to prepare a mixed sample.

[0023] In one embodiment, before the step of detecting the total original veterinary drug content of various veterinary drugs in the mixed sample by liquid chromatography tandem mass spectrometry, the method further comprises:

[0024] The veterinary drug mixed standard solution, the extraction solvent and the mixed sample are mixed and centrifuged to obtain a supernatant;

[0025] The supernatant is purified by a solid phase extraction column and concentrated by nitrogen blowing to obtain a test solution for liquid chromatography tandem mass spectrometry detection, wherein the concentration multiple of the nitrogen blowing concentration is positively correlated with the number of single samples contained in the mixed sample.

[0026] In one embodiment, before the step of providing the mixed sample, the method further comprises:

[0027] Get the expected positivity rate;

[0028] According to the expected positive rate, the number of single samples contained in the mixed sample is determined, wherein there is a negative correlation between the number of single samples and the expected positive rate.

[0029] In one embodiment, the number of the single samples is 5-10.

[0030] In one embodiment, the categories of residual veterinary drugs screened by the method include at least one of: β-agonists, glucocorticoids, tetracyclines, amides, sulfonamides, fluoroquinolones, nitroimidazoles, antivirals, anesthetics, antimicrobial enhancers and malachite green.

[0031] In one embodiment, the residual veterinary drugs screened by the method include: hydroxy metronidazole, hydroxymethyl metronidazole, amantadine, betamethasone, bromobuterol, chloramphenicol, chlortetracycline, cimaterol, cibuterol, ciprofloxacin, clenbuterol, clenserol, clenpent, clenproperol, chlorprenaline, danofloxacin, dexamethasone, diazepam, dimenolide, doxycycline, enrofloxacin, fenoterol, fleroxacin, florfenicol, florfenicol amine, flumequine, invisible malachite green, lomefloxacin, mabuterol, malachite green, mapentol, metronidazole, norfloxacin, oxygen At least one of floxacin, oxolinic acid, oxytetracycline, pefloxacin, penbuterol, ractopamine, ritodrine hydrochloride, ronidazole, salbutamol, sarafloxacin, sulfachloropyridazine, sulfadiazine, sulfamethoxine, sulfa-o-dimethoxine, sulfamethazine, sulfamethoxine, sulfamethazine, sulfamethoxazole, sulfamethoxazole, sulfamethoxazole, sulfamethoxazole, sulfamethoxazole, sulfamethoxazole, sulfamethoxazole, sulfamethoxazole, sulfamethoxazole, sulfamethoxazole, sulfamethoxazole, sulfamethoxazole, terbutaline, tetracycline, thiamphenicol, trimethoprim and tobuterol.

[0032] One or more technical solutions proposed in the embodiments of the present application have at least the following technical effects: providing a mixed sample containing multiple single samples belonging to the same animal product category, and then obtaining the original total veterinary drug content of various veterinary drugs in the mixed sample through a single injection of a liquid chromatography-tandem mass spectrometer, thereby realizing simultaneous screening of multiple veterinary drugs in the mixed sample, greatly improving the efficiency of inspection and detection work; then correcting the original veterinary drug content of various veterinary drugs according to a target standard curve matching the animal product category to which the mixed sample belongs, thereby effectively removing the matrix effect in the mixed sample and obtaining the accurate total veterinary drug content corresponding to various veterinary drugs; then, according to the target total veterinary drug content of the mixed liquid sample, the veterinary drug sub-content of each single sample contained in the mixed sample can be inferred, thereby realizing efficient mixed inspection of multiple samples; and since the single samples contained in the mixed sample are of the same animal product category, the matrix effect of the sample can be effectively removed based on the corresponding target standard curve, thereby improving the detection accuracy. BRIEF DESCRIPTION OF THE DRAWINGS

[0033] The accompanying drawings, which are incorporated in and constitute a part of this specification, illustrate embodiments consistent with the present application and, together with the description, serve to explain the principles of the present application.

[0034] In order to more clearly illustrate the technical solutions in the embodiments of the present application or the conventional technology, the drawings required for use in the embodiments or the conventional technology descriptions are briefly introduced below. Obviously, for ordinary technicians in this field, other drawings can be obtained based on these drawings without paying any creative labor.

[0035] Figure 1 Schematic diagram of the process provided for the first embodiment of the veterinary drug residue detection method of this application Figure 1 ;

[0036] Figure 2 Schematic diagram of the process provided for the first embodiment of the veterinary drug residue detection method of this application Figure 2 ;

[0037] Figure 3 The veterinary drug spectrum involved in the veterinary drug residue detection method embodiment of this application Figure 1 ;

[0038] Figure 4 The veterinary drug spectrum involved in the veterinary drug residue detection method embodiment of this application Figure 2 ;

[0039] Figure 5 The veterinary drug spectrum involved in the veterinary drug residue detection method embodiment of this application Figure 3 .

[0040] The purpose, features and advantages of this application will be further described in conjunction with the embodiments and with reference to the accompanying drawings. DETAILED DESCRIPTION

[0041] In order to make the purpose, technical scheme and advantages of the embodiments of the present application clearer, the technical scheme in the embodiments of the present application will be described clearly and completely below. If the specific conditions are not specified in the embodiments, they are carried out according to the conventional conditions or the conditions recommended by the manufacturer. If the manufacturer is not specified for the reagents or instruments used, they are all conventional products that can be purchased commercially.

[0042] Hereinafter, the embodiment of the method for recovering lithium from waste lithium iron phosphate batteries of the present application is specifically disclosed with appropriate reference to the accompanying drawings. However, there may be cases where unnecessary detailed descriptions are omitted. For example, there are cases where detailed descriptions of well-known matters and repeated descriptions of actually the same structures are omitted. This is to avoid the following description from becoming unnecessarily lengthy and to facilitate the understanding of those skilled in the art. In addition, the accompanying drawings and the following description are provided for those skilled in the art to fully understand the present application and are not intended to limit the subject matter described in the claims.

[0043] The "range" disclosed in the present application is defined in the form of a lower limit and an upper limit, and a given range is defined by selecting a lower limit and an upper limit, and the selected lower limit and upper limit define the boundaries of the particular range. The range defined in this way can be inclusive or exclusive of the end values, and can be arbitrarily combined, that is, any lower limit can be combined with any upper limit to form a range. For example, if a range of 60 to 120 and 80 to 110 is listed for a particular parameter, it is understood that a range of 60 to 110 and 80 to 120 is also expected. In addition, if the minimum range values ​​1 and 2 are listed, and if the maximum range values ​​3, 4 and 5 are listed, the following ranges can all be expected: 1 to 3, 1 to 4, 1 to 5, 2 to 3, 2 to 4 and 2 to 5. In the present application, unless otherwise specified, the numerical range "a to b" represents an abbreviation of any real number combination between a and b, where a and b are both real numbers. For example, the numerical range "0-5" means that all real numbers between "0-5" are listed in this document, and "0-5" is just an abbreviation of these numerical combinations. In addition, when a parameter is expressed as an integer ≥ 2, it is equivalent to disclosing that the parameter is, for example, an integer of 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, etc.

[0044] Unless otherwise specified, all embodiments and optional embodiments of the present application can be combined with each other to form a new technical solution.

[0045] Unless otherwise specified, all technical features and optional technical features of this application can be combined with each other to form a new technical solution.

[0046] Unless otherwise specified, all steps of the present application may be performed sequentially or randomly, preferably sequentially. For example, a method includes steps (a) and (b), which means that the method may include steps (a) and (b) performed sequentially, or may include steps (b) and (a) performed sequentially. For example, a method may also include step (c), which means that step (c) may be added to the method in any order, for example, the method may include steps (a), (b) and (c), or may include steps (a), (c) and (b), or may include steps (c), (a) and (b), etc.

[0047] If there is no special explanation, the "include" and "comprising" mentioned in this application represent open-ended or closed-ended expressions. For example, "include" and "comprising" may represent that other components not listed may also be included or only listed components may be included or only listed components may be included.

[0048] If not specifically stated, in this application, the term "or" is inclusive. For example, the phrase "A or B" means "A, B, or both A and B". More specifically, any of the following conditions satisfies the condition "A or B": A is true (or exists) and B is false (or does not exist); A is false (or does not exist) and B is true (or exists); or both A and B are true (or exist).

[0049] In order to make the above-mentioned purposes, features and advantages of the present application more obvious and understandable, the technical solution of the present application is further described below in conjunction with the accompanying drawings and embodiments. However, the present application is not limited to the listed embodiments, and should also include any other known changes within the scope of the rights claimed in the present application.

[0050] The term "one embodiment" or "embodiment" as used herein refers to a specific feature, structure, or characteristic that may be included in at least one implementation of the present application. The term "in one embodiment" that appears in different places in this specification does not necessarily refer to the same embodiment, nor does it refer to a separate or selective embodiment that is mutually exclusive with other embodiments.

[0051] In conventional technology, with the increasingly stringent food safety standards, the monitoring of veterinary drug residues in animal agricultural products has been significantly strengthened; and veterinary drug residue detection has three characteristics, namely: large number of detections, low excess rate (usually below 2%), and the excess rate is decreasing year by year. Therefore, the conventional single sample detection method is time-consuming and laborious, and it is of great value to develop an accurate, reliable, efficient and rapid veterinary drug residue detection method.

[0052] The present application provides a solution, which first provides a mixed sample containing multiple single samples belonging to the same animal product category, and then obtains the original total veterinary drug content of various veterinary drugs in the mixed sample through a single injection of a liquid chromatography-tandem mass spectrometer, thereby realizing simultaneous screening of multiple veterinary drugs in the mixed sample, greatly improving the efficiency of inspection and detection work; then, according to a target standard curve matching the animal product category to which the mixed sample belongs, the original veterinary drug content of various veterinary drugs is corrected, the matrix effect in the mixed sample is effectively removed, and the accurate total veterinary drug content corresponding to various veterinary drugs is obtained; then, according to the target total veterinary drug content of the mixed liquid sample, the veterinary drug sub-content of each single sample contained in the mixed sample can be inferred, thereby realizing efficient mixed inspection of multiple samples; and since the single samples contained in the mixed sample are of the same animal product category, the matrix effect of the sample can be effectively removed based on the corresponding target standard curve, thereby improving detection accuracy.

[0053] The first aspect of the present application provides a method for detecting veterinary drug residues, referring to Figure 1 , including the following steps:

[0054] Step S10, providing a mixed sample, wherein the mixed sample includes a plurality of single samples belonging to the same animal product category;

[0055] In one possible embodiment, single samples belonging to the same animal product category are prepared into a composite sample for veterinary drug residue detection.

[0056] Exemplarily, the animal product category may include livestock and poultry, aquatic products and eggs. Therefore, single samples belonging to the livestock and poultry, aquatic products or eggs may be mixed to prepare a single mixed sample.

[0057] It should be understood that the embodiments of the present application are also applicable to the detection of veterinary drug residues in a single sample, and the processing steps and testing process for a single sample are the same as the testing process for a mixed sample. Exemplarily, a single sample is provided, and the original veterinary drug content of each type of veterinary drug in the single sample is detected by a liquid chromatography-tandem mass spectrometer; a target standard curve matching the animal category of the single sample is determined, and the original veterinary drug content of each type of veterinary drug in the single sample is corrected according to the target curve to obtain the target veterinary drug content of each type of veterinary drug; when the target veterinary drug content of each type of veterinary drug in the single sample is less than the preset veterinary drug limit value, the single sample is determined to be a negative sample; or, when the target veterinary drug content in the single sample is greater than or equal to the veterinary drug limit value, the single sample is determined to be a positive sample.

[0058] The above method can realize the veterinary drug residue detection of a single sample, and the categories of residual veterinary drugs that can be screened include: at least one of: β-stimulants, glucocorticoids, tetracyclines, amides, sulfonamides, fluoroquinolones, nitroimidazoles, antivirals, anesthetics, antibacterial enhancers and malachite green. The residual veterinary drugs that can also be screened by the above method include: hydroxy metronidazole, hydroxymethyl metronidazole, amantadine, betamethasone, bromobuterol, chloramphenicol, chlortetracycline, cimaterol, sibuterol, ciprofloxacin, clenbuterol, clenserol, clenpent, clenproperol, chlorprenaline, danofloxacin, dexamethasone, diazepam, dimenidazole, doxycycline, enrofloxacin, fenoterol, fleroxacin, florfenicol, florfenicol amine, flumequine, invisible malachite green, lomefloxacin, mabuterol, malachite green, mapentol, metronidazole, norfloxacin, oxalofloxacin, At least one of floxacin, oxolinic acid, oxytetracycline, pefloxacin, penbuterol, ractopamine, ritodrine hydrochloride, ronidazole, salbutamol, sarafloxacin, sulfachloropyridazine, sulfadiazine, sulfamethoxine, sulfa-o-dimethoxine, sulfamethoxine, sulfamethoxine, sulfamethoxazole, sulfamethoxazole, sulfamethoxazole, sulfamethoxazole, sulfamethoxazole, sulfamethoxazole, sulfamethoxazole, sulfamethoxazole, sulfamethoxazole, sulfamethoxazole, sulfamethoxazole, sulfamethoxazole, sulfamethoxazole, terbutaline, tetracycline, thiamphenicol, trimethoprim and tobuterol. That is, high-throughput determination of 64 kinds of animal residues in 11 categories in a single sample is achieved, effectively improving the detection efficiency of veterinary drug residues.

[0059] In one possible implementation, referring to Figure 2 , step S10, the step of providing a mixed sample comprises:

[0060] Step S11, obtaining the product to be inspected and crushing it to obtain a preparatory single sample, wherein the mass of the product to be inspected is greater than the mass of the preparatory single sample;

[0061] Step S12, taking part of the samples from the prepared single samples as the target single samples;

[0062] Step S13, mixing multiple target single samples belonging to the same animal product category to obtain a mixed sample.

[0063] In a feasible embodiment, a product to be inspected is obtained, and the product to be inspected is crushed by a tissue crusher, and a portion of the crushed product to be inspected is taken as a preparatory single sample for standby use. A portion of the sample is taken from the preparatory single sample as a target single sample, and then multiple target single samples belonging to the same animal product category are mixed and stirred by a tissue crusher until uniform, and a portion of the sample is taken to obtain a mixed sample.

[0064] For example, 1 kg of the product to be tested is obtained, cut into small pieces and fully crushed with a tissue grinder, and 300 g is taken as a preparatory single sample and frozen for storage. 30 g of the sample is taken from the preparatory single sample as a target single sample, and multiple target single samples belonging to the same animal product category are mixed and stirred with a tissue grinder until uniform to obtain a mixed sample.

[0065] In this embodiment, the uniformity of the final mixed sample is ensured by multiple partial sampling, stirring and mixing, so that the mixed sample can repeatedly represent each single sample it contains, thereby improving the detection accuracy.

[0066] In a feasible implementation manner, before the step of providing a mixed sample in step S10, the method further includes:

[0067] Step S14, obtaining the expected positive rate;

[0068] Step S15, determining the number of single samples contained in the mixed sample according to the expected positive rate, wherein there is a negative correlation between the number of single samples and the expected positive rate.

[0069] It should be understood that the detection efficiency of the veterinary drug residue detection method needs to be increased by more than 3 times to reflect its advantages and significance; and when it is determined that the test result of the mixed sample is that there is a suspected positive sample, it is necessary to retest the suspected positive samples in the mixed sample one by one, that is, to increase the number of tests. Therefore, the number of single samples contained in the mixed sample has a greater impact on the overall detection efficiency.

[0070] In a feasible embodiment, in order to determine the number of single samples contained in the mixed sample, the expected positive rate is obtained, wherein the expected positive rate is determined based on historical test data or through a sampling survey; and then based on the expected positive rate, the number of single samples contained in the mixed sample is determined, wherein there is a negative correlation between the number of single samples and the expected positive rate.

[0071] Exemplarily, taking 100 single samples as an example to calculate the maximum detection amount, assuming that the highest positive rate is B, the number of single samples in the mixed sample (i.e., the number of mixed samples) is N, and the maximum number of tests is: 100 single samples / number of mixed samples N + 100 samples × highest positive rate B × number of mixed samples N, and the maximum number of tests should be less than the number of tests for 100 samples tested one by one, so: 1 / N+NB<1. Furthermore, if B<9%, then N=10, and if B<16%, then N=5. Since the purpose of mixed sample testing is to minimize the number of tests, it is meaningful for the expected positive rate to be at least 3 times lower than the highest positive rate, that is, when the expected positive rate is <3%, N can reach 10; and when the expected positive rate is >3% and <5%, N can reach 5, so that the detection efficiency can be greatly improved.

[0072] In one feasible implementation, the number of single samples is 5-10.

[0073] Exemplarily, the number of single samples is 5, 6, 7, 8, 9 or 10.

[0074] For example, the expected positive rate is less than 3%, and the number of single samples is 10. In this case, the detection efficiency can be increased by 9 times.

[0075] For example, if there are 100 single samples with an excess rate of 2.0%, 10 mixed samples can be formed when the number of mixed samples is set to 10. Conventional methods require the detection of 100 single samples; while the embodiment of the present application uses the mixed detection method to detect 10 mixed samples for the first time. Since the excess rate is only 2%, there are a maximum of 20 suspected positive samples and a minimum of 2 suspected positive samples; that is, a maximum of 20 single samples and a minimum of 2 single samples need to be retested. Furthermore, it is determined that the total number of samples for initial inspection and retest is 12 to 30 samples, so that the detection efficiency can be greatly improved.

[0076] In this embodiment, the detection efficiency is greatly improved by setting the number of single samples.

[0077] Step S20, detecting the total original veterinary drug content of various veterinary drugs in the mixed sample by liquid chromatography tandem mass spectrometry;

[0078] In a feasible embodiment, the total veterinary drug content of each type of veterinary drug in the mixed sample (ie, the total original veterinary drug content) is detected by liquid chromatography tandem mass spectrometry.

[0079] Exemplarily, the test conditions of liquid chromatography include: chromatographic column is C18 (2.1 mm (inner diameter) × 100 mm, 1.8 μm); column temperature: 40° C.; injection volume: 5 μL; flow rate: 0.3 mL / min; mobile phase: phase A is ammonium formate (5 mmol / L)-0.1% formic acid aqueous solution, phase B is methanol, and the parameters refer to the following Table 1:

[0080] Table 1:

[0081]

[0082]

[0083] Among them, V A is the volume of phase A, V B is the volume of phase B.

[0084] Exemplary, the test conditions of mass spectrometry include: ion source type - electrospray ion source; scanning mode: ESI+ / -; electrospray voltage: positive ion 5500V, negative ion -4500V; ion source temperature 350°C; nebulizer gas: 60psi; auxiliary heating gas: 55psi; curtain gas: 40psi; detection mode: multiple reaction monitoring mode (MRM).

[0085] For example, the mass spectrometry ion pairs of 40 pesticides in the examples of this application refer to the following Table 2:

[0086] Table 2:

[0087]

[0088]

[0089]

[0090] In a feasible implementation manner, before the step of detecting the total original veterinary drug content of various veterinary drugs in the mixed sample by liquid chromatography tandem mass spectrometry in step S20, the method further includes:

[0091] Step S21, mixing the veterinary drug mixed standard solution, the extraction solvent and the mixed sample and centrifuging to obtain a supernatant;

[0092] In a feasible embodiment, the mixed sample is placed in a plastic centrifuge tube, and the drug mixed standard solution and the extraction solvent are added in sequence. After being fully mixed, the mixture is vigorously shaken for 3 to 20 minutes and centrifuged; after centrifugation, the supernatant is extracted.

[0093] Step S22, purifying the supernatant by a solid phase extraction column and concentrating it by nitrogen blowing to obtain a test solution for liquid chromatography tandem mass spectrometry detection, wherein the concentration multiple of nitrogen blowing concentration is positively correlated with the number of single samples contained in the mixed sample.

[0094] In one feasible embodiment, the supernatant is purified by a solid phase extraction column and concentrated by nitrogen blowing. The residual liquid is fixed to volume with a methanol-water solution and then filtered through a filter membrane to obtain a test liquid. The test liquid can then be detected by a liquid chromatography-tandem mass spectrometer to obtain the original total veterinary drug content of various veterinary drugs in the mixed sample.

[0095] Exemplarily, 5 g of the mixed sample is weighed and placed in a 50 mL plastic centrifuge tube, and the veterinary drug mixed standard solution and 10 mL of acetonitrile aqueous solution (80 wt.% acetonitrile + 20 wt.% water + 0.2 wt.% formic acid) are added. After being fully mixed, it is vigorously shaken for 5 minutes; then centrifuged for 6 minutes by a 10000 r / min high-speed refrigerated centrifuge, and 5 mL of supernatant is extracted. The supernatant is purified by a PRIMEHLB solid phase extraction column, and all the effluent is collected with a glass tube, and concentrated 5 times by nitrogen blowing in a 40°C water bath. The residual liquid is fixed to 0.5 mL with a methanol aqueous solution (90 wt.% water + 10 wt.% methanol + 0.1 wt.% methanol), and passed through a 0.22 μm filter membrane to obtain a test solution.

[0096] In this embodiment, mixing multiple single samples into a mixed sample is equivalent to diluting the sample multiple times, which may result in reduced detection sensitivity. In order to ensure detection accuracy, the embodiment of the present application uses nitrogen blowing to concentrate and increase the sample loading amount of the liquid chromatography tandem mass spectrometer to ensure that the sensitivity of each component in the mixed sample reaches the single sample detection level.

[0097] Step S30, correcting the original veterinary drug content of each type of veterinary drug according to the target standard curve that matches the animal product category to which the mixed sample belongs, to obtain the target total veterinary drug content of each type of veterinary drug;

[0098] In a feasible embodiment, a plurality of standard curves corresponding to different animal product categories are pre-established. Therefore, a target standard curve can be matched according to the animal product category to which the mixed sample belongs; and then, the original veterinary drug content of each type of veterinary drug is corrected according to the target standard curve to eliminate the matrix effect and obtain the target total veterinary drug content of each type of veterinary drug.

[0099] It should be understood that the matrix effect varies greatly between animal products of different species, and the matrix effect is more significant in mixed samples because multiple single samples are mixed in and concentrated by the detector.

[0100] Exemplarily, common single samples of livestock and poultry, aquatic products and eggs were selected to form livestock and poultry mixed samples, aquatic products mixed samples and egg mixed samples for matrix effect experiments. The results showed that the matrix effect of the mixed samples was 150-500%. Therefore, the influence of the matrix effect cannot be ignored.

[0101] In one feasible embodiment, before the step of correcting the original veterinary drug content of each type of veterinary drug according to the target standard curve matching the animal product category to which the mixed sample belongs in step S30, the method further includes:

[0102] Step S31, using pork as a blank matrix to establish a standard curve matching livestock and poultry;

[0103] Step S32, using fish meat as a blank matrix, establishing a standard curve matching aquatic products;

[0104] Step S33, using eggs as blank matrix, establishing an egg-matched standard curve.

[0105] In a feasible embodiment, pork, fish and eggs, whose matrix effects are closest to those of various mixed samples, are selected as negative matrix preparation standards for the quantitative analysis of mixed samples, that is, pork, fish and eggs are used as blank matrices, matrix standard solutions are prepared, and matrix effect evaluation is performed to obtain standard curves corresponding to livestock and poultry, aquatic products and eggs, respectively; wherein the concentrations in the standard curves include: 0.020 μg / kg, 0.050 μg / kg, 0.10 μg / kg, 0.20 μg / kg, 0.20 μg / kg, 1.0 μg / kg and 2.0 μg / kg.

[0106] In this embodiment, pork, fish and eggs, whose matrix effects are closest to those of various mixed samples, are selected as blank matrices to establish a standard curve, so as to effectively eliminate the matrix effect in the original veterinary drug content; in addition, the solid phase extraction column performs reverse phase purification on the acidic, alkaline and neutral compounds in the mixed sample matrix, effectively removing the interfering matrix of the sample to improve the detection accuracy.

[0107] Step S40, determining the veterinary drug sub-content of each veterinary drug of each single sample contained in the mixed sample according to the target total veterinary drug content of each veterinary drug.

[0108] In a feasible embodiment, the veterinary drug sub-content of each veterinary drug in each single sample included in the mixed sample is calculated based on the target total veterinary drug content of each veterinary drug.

[0109] In a feasible implementation, step S40, the step of determining the veterinary drug sub-content of each veterinary drug of each single sample contained in the mixed sample according to the target total veterinary drug content of each veterinary drug, comprises:

[0110] Step S41, determining the veterinary drug sub-content of each veterinary drug in each single sample contained in the mixed sample according to the target total veterinary drug content of each veterinary drug and the number of single samples contained in the mixed sample, wherein the veterinary drug sub-content and the number of single samples are positively correlated.

[0111] In a feasible embodiment, the product of the target total veterinary drug content of each type of veterinary drug in the mixed sample and the number of single samples contained in the mixed sample is determined as the veterinary drug sub-content of each type of veterinary drug in the single sample.

[0112] In a feasible implementation manner, after the step of determining the veterinary drug sub-content of each veterinary drug of each single sample contained in the mixed sample according to the target total veterinary drug content of each veterinary drug in step S40, the method further includes:

[0113] Step S42, when the veterinary drug sub-content of each veterinary drug in each single sample contained in the mixed sample is less than the preset veterinary drug limit value, it is determined that each single sample contained in each mixed sample is a negative sample; or,

[0114] In a feasible embodiment, when the veterinary drug sub-content of each type of veterinary drug in each single sample included in the mixed sample is less than the preset veterinary drug limit value, it is determined that each single sample included in each mixed sample has passed the test, that is, it is a negative sample.

[0115] Step S43, when the single sample contained in the mixed sample has a corresponding veterinary drug content greater than or equal to the preset veterinary drug limit value, the single sample with the veterinary drug content greater than or equal to the veterinary drug limit value is determined as a suspected positive sample, and the suspected positive sample is retested as a single sample.

[0116] In a feasible embodiment, when the corresponding veterinary drug content in a single sample included in the mixed sample is greater than or equal to the preset veterinary drug limit value, it is indicated that a single sample has failed the test, and the single sample with the veterinary drug content greater than or equal to the veterinary drug limit value is determined as a suspected positive sample, and the suspected positive sample is retested with a single sample, wherein the retesting method is the same as the conventional single sample testing method.

[0117] Exemplarily, the mixed sample includes single samples 1 to 10, and the types of residual veterinary drugs screened include: veterinary drug A and veterinary drug B; it is determined that among single samples 1 to 10, the veterinary drug sub-content of veterinary drug A in single sample 1 is greater than the veterinary drug limit value of veterinary drug A, and then veterinary drug A in single sample 1 is re-tested.

[0118] In one feasible embodiment, the categories of residual veterinary drugs screened by the present application include at least one of: β-stimulants, glucocorticoids, tetracyclines, amides, sulfonamides, fluoroquinolones, nitroimidazoles, antivirals, anesthetics, antimicrobial enhancers and malachite green.

[0119] In a feasible embodiment, the residual veterinary drugs screened by the present application include: hydroxy metronidazole, hydroxymethyl metronidazole, amantadine, betamethasone, bromobuterol, chloramphenicol, chlortetracycline, cimaterol, cibuterol, ciprofloxacin, clenbuterol, clenserol, clenpent, clenproperol, chlorprenaline, danofloxacin, dexamethasone, diazepam, dimenidazole, doxycycline, enrofloxacin, fenoterol, fleroxacin, florfenicol, florfenicol amine, flumequine, invisible malachite green, lomefloxacin, mabuterol, malachite green, mapentol, metronidazole, norfloxacin, At least one of ofloxacin, oxolinic acid, oxytetracycline, pefloxacin, penbuterol, ractopamine, ritodrine hydrochloride, ronidazole, salbutamol, sarafloxacin, sulfachloropyridazine, sulfadiazine, sulfamethoxine, sulfa-o-dimethoxine, sulfamethazine, sulfamethoxine, sulfamethazine, sulfamethoxazole, sulfamethoxazole, sulfamethoxazole, sulfamethoxazole, sulfamethoxazole, sulfamethoxazole, sulfamethoxazole, sulfamethoxazole, sulfamethoxazole, sulfamethoxazole, sulfamethoxazole, sulfamethoxazole, terbutaline, tetracycline, thiamphenicol, trimethoprim and tobuterol.

[0120] For example, refer to Figures 3 to 5 , which is a spectrum of 64 veterinary drugs that can be detected in the embodiment of the present application, wherein the horizontal axis is time and the vertical axis is intensity, specifically including: hydroxymetronidazole, hydroxymethylmetronidazole, amantadine, betamethasone, bromobuterol, chloramphenicol, chlortetracycline, cimaterol, sibuterol, ciprofloxacin, clenbuterol, clenserol, clenpent, clenproperol, chlorprenaline, danofloxacin, dexamethasone, diazepam, dimenolide, doxycycline, enrofloxacin, fenoterol, fleroxacin, florfenicol, florfenicol amine, flumequine, invisible malachite green, lomefloxacin, mabuterol, malachite green, Mapentol, metronidazole, norfloxacin, ofloxacin, oxolinic acid, oxytetracycline, pefloxacin, penbuterol, ractopamine, ritodrine hydrochloride, ronidazole, salbutamol, sarafloxacin, sulfachloropyridazine, sulfadiazine, sulfamethoxazole, sulfamethoxazole, sulfamethoxazole, sulfamethoxazole, sulfamethoxazole, sulfamethoxazole, sulfamethoxazole, sulfamethoxazole, sulfamethoxazole, sulfamethoxazole, sulfamethoxazole, sulfamethoxazole, sulfamethoxazole, sulfamethoxazole, sulfamethoxazole, sulfamethoxazole, terbutaline, tetracycline, thiamphenicol, trimethoprim, and tobutrol.

[0121] Exemplarily, the quantitative limit of the method in the embodiment of the present application is 0.02-0.1 μg / kg, which is one tenth of the current national standard method; that is, when the number of single samples contained in the maximum mixed sample is 10, the recovery rate of the present application is calculated to be the same as the national standard method. The recovery test was carried out on the embodiment of the present application, wherein 10 single samples were selected as the mixed matrix. The concentration of the standard substance with known concentration added to each single sample includes: low concentration (0.2-1 μg / kg), medium concentration (2-10 μg / kg) and high concentration (10-200 μg / kg), and each sample concentration level was repeated 6 times, each time using a different single sample to reduce accidental errors and improve the reliability of the results. The experimental results show that when the concentrations are: 0.2-1 μg / kg, 2-10 μg / kg and 10 μg / kg, the recovery rate is 60-120%, and when the concentration is 200 μg / kg, the recovery rate is 80-110%. When the concentration is 0.2-1μg / kg, the coefficient of variation is below 30%; when the concentration is 2-10μg / kg, the coefficient of variation is below 21%; when the concentration is 10μg / kg, the coefficient of variation is below 21%; when the concentration is 200μg / kg, the coefficient of variation is below 11%, all of which meet the national standard requirements.

[0122] In this embodiment, a mixed sample containing multiple single samples belonging to the same animal product category is first provided, and then the original total veterinary drug content of various veterinary drugs in the mixed sample is obtained by a single injection of a liquid chromatography tandem mass spectrometer, thereby realizing simultaneous screening of multiple veterinary drugs in the mixed sample, greatly improving the efficiency of inspection and detection work; then, according to the target standard curve that matches the animal product category to which the mixed sample belongs, the original veterinary drug content of various veterinary drugs is corrected, thereby realizing effective removal of the matrix effect in the mixed sample, and obtaining the accurate total veterinary drug content corresponding to various veterinary drugs; then, according to the target total veterinary drug content of the mixed liquid sample, the veterinary drug sub-content of each single sample contained in the mixed sample can be inferred, thereby realizing efficient mixed inspection of multiple samples; and since the animal product category of the single samples contained in the mixed sample is the same, the matrix effect of the sample can be effectively removed based on the corresponding target standard curve, thereby improving detection accuracy. The embodiment of the present application realizes high-throughput determination of 64 veterinary drug residues in 11 categories.

[0123] The above are only some embodiments of the present application, and are not intended to limit the patent scope of the present application. All equivalent structural changes made using the contents of the present application specification and drawings under the technical concept of the present application, or direct / indirect application in other related technical fields are included in the patent protection scope of the present application.

Claims

1. A method for detecting veterinary drug residues, characterized in that: The method includes: providing a composite sample, wherein the composite sample comprises a plurality of individual samples belonging to the same animal product category; Detecting the total original veterinary drug content of various veterinary drugs in the mixed sample by liquid chromatography tandem mass spectrometry; Correcting the original veterinary drug content of each type of veterinary drug according to a target standard curve that matches the animal product category to which the mixed sample belongs, to obtain a target total veterinary drug content of each type of veterinary drug; According to the target total veterinary drug content of each type of veterinary drug, the veterinary drug sub-content of each type of veterinary drug in each single sample contained in the mixed sample is determined.

2. The method according to claim 1, characterized in that The animal product categories include livestock and poultry, aquatic products and eggs. Before the step of correcting the original veterinary drug content of each type of veterinary drug according to the target standard curve matching the animal product category to which the mixed sample belongs to obtain the target total veterinary drug content of each type of veterinary drug, the step further includes: Pork was used as a blank matrix to establish a standard curve matching livestock and poultry; Using fish meat as blank matrix, a standard curve matching aquatic products was established; Eggs were used as blank matrix to establish an egg-matched standard curve.

3. The method according to claim 1, characterized in that After the step of determining the veterinary drug sub-content of each type of veterinary drug in each single sample contained in the mixed sample, the method further includes: In the case where the veterinary drug sub-content of each veterinary drug in each single sample contained in the mixed sample is less than the preset veterinary drug limit value, it is determined that each single sample contained in the mixed sample is a negative sample; or, In the event that the corresponding veterinary drug content in a single sample contained in the mixed sample is greater than or equal to the preset veterinary drug limit value, the single sample with the veterinary drug content greater than or equal to the veterinary drug limit value is determined as a suspected positive sample, and the suspected positive sample is retested as a single sample.

4. The method according to claim 1, characterized in that The step of determining the veterinary drug sub-content of each veterinary drug of each single sample contained in the mixed sample according to the target veterinary drug total content of each veterinary drug comprises: According to the total target veterinary drug content of each type of veterinary drug and the number of single samples contained in the mixed sample, the veterinary drug sub-content of each type of veterinary drug in each single sample contained in the mixed sample is determined, wherein the veterinary drug sub-content and the number of single samples are positively correlated.

5. The method according to claim 1, characterized in that The step of providing a mixed sample comprises: Obtaining the product to be inspected and crushing it to obtain a preparatory single sample, wherein the mass of the product to be inspected is greater than the mass of the preparatory single sample; Taking a portion of the sample from the prepared single sample as the target single sample; A plurality of the target single samples belonging to the same animal product category are mixed evenly to prepare a mixed sample.

6. The method according to claim 1, characterized in that Before the step of detecting the total original veterinary drug content of various veterinary drugs in the mixed sample by liquid chromatography tandem mass spectrometry, the method further comprises: The veterinary drug mixed standard solution, the extraction solvent and the mixed sample are mixed and centrifuged to obtain a supernatant; The supernatant is purified by a solid phase extraction column and concentrated by nitrogen blowing to obtain a test solution for liquid chromatography tandem mass spectrometry detection, wherein the concentration multiple of the nitrogen blowing concentration is positively correlated with the number of single samples contained in the mixed sample.

7. The method according to claim 1, characterized in that Before the step of providing the mixed sample, the method further comprises: Get the expected positivity rate; According to the expected positive rate, the number of single samples contained in the mixed sample is determined, wherein there is a negative correlation between the number of single samples and the expected positive rate.

8. The method according to claim 7, characterized in that The number of the single samples is 5 to 10.

9. The method according to claim 1, characterized in that The categories of residual veterinary drugs screened by the method include at least one of: beta-stimulants, glucocorticoids, tetracyclines, amides, sulfonamides, fluoroquinolones, nitroimidazoles, antivirals, anesthetics, antibacterial enhancers and malachite green.

10. The method according to claim 9, characterized in that The residual veterinary drugs screened by the method include: hydroxy metronidazole, hydroxymethyl metronidazole, amantadine, betamethasone, bromobuterol, chloramphenicol, chlortetracycline, cimaterol, cibuterol, ciprofloxacin, clenbuterol, clenserol, clenpent, clenproperol, chlorprenaline, danofloxacin, dexamethasone, diazepam, dimenidazole, doxycycline, enrofloxacin, fenoterol, fleroxacin, florfenicol, florfenicol amine, flumequine, invisible malachite green, lomefloxacin, mabuterol, malachite green, mapentol, metronidazole, norfloxacin, ofloxacin , oxolinic acid, oxytetracycline, pefloxacin, penbuterol, ractopamine, ritodrine hydrochloride, ronidazole, salbutamol, sarafloxacin, sulfachloropyridazine, sulfadiazine, sulfamethoxazole, sulfamethoxazole, sulfamethoxazole, sulfamethoxazole, sulfamethoxazole, sulfamethoxazole, sulfamethoxazole, sulfamethoxazole, sulfamethoxazole, sulfamethoxazole, sulfamethoxazole, sulfamethoxazole, sulfamethoxazole, sulfamethoxazole, terbutaline, tetracycline, thiamphenicol, trimethoprim and tobuterol.